• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转化生长因子β1-微小RNA-140-5p轴介导的瓣内切酶1上调促进肝细胞癌上皮-间质转化

TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.

作者信息

Li Chuanfei, Zhou Di, Hong Hao, Yang Shuangyan, Zhang Li, Li Shiying, Hu Peng, Ren Hong, Mei Zhechuan, Tang Hui

机构信息

Department of Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.

Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 4001016, China.

出版信息

Aging (Albany NY). 2019 Aug 10;11(15):5593-5612. doi: 10.18632/aging.102140.

DOI:10.18632/aging.102140
PMID:31402791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6710057/
Abstract

Flap Endonuclease 1 (FEN1) is a known oncogene in an array of cancers, but its role in hepatocellular carcinoma (HCC) remains obscure. In this study, we report that FEN1 expression was elevated in the Cancer Genome Atlas (TCGA) database which was verified in HCC tissue and hepatoma cell lines. Pearson correlation analysis indicated that FEN1 was involved in HCC metastasis. We demonstrated that FEN1 silencing inhibits HCC cell epithelial-mesenchymal transition (EMT), invasion and migration and significantly suppressed tumor growth and metastasis . Conversely, FEN1 overexpression in HCC cells enhanced these metastatic processes. We further confirmed that FEN1 was a direct target of miR-140-5p, which was down-regulated in HCC tissues, and negatively correlated with FEN1 expression. Moreover, low miR-140-5p levels and high FEN1 expression predicted a poor clinical outcome. The effects of FEN1 overexpression could be partially abolished by miR-140-5p. miR-140-5p down-regulation and FEN1 overexpression were observed in a TGFβ1 induced EMT model. TGFβ1 mediated EMT could be blocked by miR-140-5p overexpression or FEN1 silencing. Taken together, our findings suggest that FEN1 is regulated by the TGFβ1- miR-140-5p axis and promotes EMT in HCC.

摘要

瓣内切核酸酶1(FEN1)在一系列癌症中是已知的癌基因,但其在肝细胞癌(HCC)中的作用仍不清楚。在本研究中,我们报告在癌症基因组图谱(TCGA)数据库中FEN1表达升高,这在HCC组织和肝癌细胞系中得到验证。Pearson相关性分析表明FEN1参与HCC转移。我们证明FEN1沉默抑制HCC细胞上皮-间质转化(EMT)、侵袭和迁移,并显著抑制肿瘤生长和转移。相反,HCC细胞中FEN1过表达增强了这些转移过程。我们进一步证实FEN1是miR-140-5p的直接靶标,miR-140-5p在HCC组织中下调,且与FEN1表达呈负相关。此外,低水平的miR-140-5p和高水平的FEN1表达预示着不良的临床结果。miR-140-5p可部分消除FEN1过表达的影响。在TGFβ1诱导的EMT模型中观察到miR-140-5p下调和FEN1过表达。miR-140-5p过表达或FEN1沉默可阻断TGFβ1介导的EMT。综上所述,我们的研究结果表明FEN1受TGFβ1-miR-140-5p轴调控,并促进HCC中的EMT。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/10b1e9f4e965/aging-11-102140-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/c74d9380d065/aging-11-102140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/3ab82f950cb4/aging-11-102140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/97ac45447635/aging-11-102140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/d95809afa704/aging-11-102140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/6c57ab06e833/aging-11-102140-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/d6b305ed9206/aging-11-102140-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/f3e87b7b7b1e/aging-11-102140-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/07f6edbc79db/aging-11-102140-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/fb4b03f187e0/aging-11-102140-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/10b1e9f4e965/aging-11-102140-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/c74d9380d065/aging-11-102140-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/3ab82f950cb4/aging-11-102140-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/97ac45447635/aging-11-102140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/d95809afa704/aging-11-102140-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/6c57ab06e833/aging-11-102140-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/d6b305ed9206/aging-11-102140-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/f3e87b7b7b1e/aging-11-102140-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/07f6edbc79db/aging-11-102140-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/fb4b03f187e0/aging-11-102140-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aad/6710057/10b1e9f4e965/aging-11-102140-g010.jpg

相似文献

1
TGFβ1- miR-140-5p axis mediated up-regulation of Flap Endonuclease 1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma.转化生长因子β1-微小RNA-140-5p轴介导的瓣内切酶1上调促进肝细胞癌上皮-间质转化
Aging (Albany NY). 2019 Aug 10;11(15):5593-5612. doi: 10.18632/aging.102140.
2
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.微小RNA-199b-5p减弱转化生长因子-β1诱导的肝细胞癌上皮-间质转化
Br J Cancer. 2017 Jul 11;117(2):233-244. doi: 10.1038/bjc.2017.164. Epub 2017 Jun 6.
3
TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis.TGF-β1 诱导的 LINC01094 通过 miR-122-5p/TGFBR2-SAMD2-SMAD3 轴促进肝癌中的上皮-间充质转化。
Funct Integr Genomics. 2024 Jul 12;24(4):123. doi: 10.1007/s10142-024-01403-1.
4
GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.GP73 通过激活 TGF-β1/Smad2 信号通路促进肝癌细胞的上皮间质转化和侵袭。
Carcinogenesis. 2018 Jul 3;39(7):900-910. doi: 10.1093/carcin/bgy010.
5
Exosomal miR-374c-5p derived from mesenchymal stem cells suppresses epithelial-mesenchymal transition of hepatocellular carcinoma via the LIMK1-Wnt/β-catenin axis.间充质干细胞来源的外泌体miR-374c-5p通过LIMK1-Wnt/β-连环蛋白轴抑制肝细胞癌的上皮-间质转化。
Environ Toxicol. 2023 May;38(5):1038-1052. doi: 10.1002/tox.23746. Epub 2023 Feb 1.
6
miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.微小RNA-139-5p通过靶向锌指E盒结合蛋白1和锌指E盒结合蛋白2抑制肝癌细胞的上皮-间质转化、迁移和侵袭。
Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27.
7
CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.CASC15 通过海绵吸附 miR-33a-5p 增加 TWIST1 基因表达促进上皮间质转化并促进肝癌细胞的恶性转化。
Eur J Pharmacol. 2019 Oct 5;860:172589. doi: 10.1016/j.ejphar.2019.172589. Epub 2019 Aug 8.
8
MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.微小RNA-379-5p通过靶向肝细胞癌中的FAK/AKT信号传导抑制肿瘤侵袭和转移。
Cancer Lett. 2016 May 28;375(1):73-83. doi: 10.1016/j.canlet.2016.02.043. Epub 2016 Mar 2.
9
MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.微小 RNA-1296 通过靶向 SRPK1 介导的 PI3K/AKT 通路抑制肝癌的转移和上皮-间充质转化。
Mol Cancer. 2017 Jun 12;16(1):103. doi: 10.1186/s12943-017-0675-y.
10
MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.微小RNA-425-5p通过SCAI介导的多种信号通路失调促进肝癌细胞的侵袭和转移。
Oncotarget. 2017 May 9;8(19):31745-31757. doi: 10.18632/oncotarget.15958.

引用本文的文献

1
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.
2
FEN1 Promotes Hepatocellular Carcinoma Progression by Activating Cell Cycle Transition from G2 To M Phase.FEN1通过激活从G2期到M期的细胞周期转换促进肝细胞癌进展。
J Cancer. 2024 Jan 1;15(4):981-989. doi: 10.7150/jca.88160. eCollection 2024.
3
Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.

本文引用的文献

1
MicroRNAs and signaling networks involved in epithelial-mesenchymal transition.微小 RNA 与信号网络在上皮-间质转化中的作用。
J Cell Physiol. 2019 May;234(5):5775-5785. doi: 10.1002/jcp.27489. Epub 2018 Nov 11.
2
Versatile Types of DNA-Based Nanobiosensors for Specific Detection of Cancer Biomarker FEN1 in Living Cells and Cell-Free Systems.基于 DNA 的多功能纳米生物传感器,用于特异性检测活细胞和无细胞体系中的癌症生物标志物 FEN1。
Nano Lett. 2018 Nov 14;18(11):7383-7388. doi: 10.1021/acs.nanolett.8b03724. Epub 2018 Oct 18.
3
Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
微小 RNA 的参与及其在肝细胞癌中的潜在诊断、治疗和预后作用。
J Clin Lab Anal. 2022 Oct;36(10):e24673. doi: 10.1002/jcla.24673. Epub 2022 Aug 29.
4
Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy.靶向 FEN1 的小分子抑制剂在癌症治疗中的应用。
Biomolecules. 2022 Jul 20;12(7):1007. doi: 10.3390/biom12071007.
5
miR-4324 inhibits ovarian cancer progression by targeting FEN1.miR-4324 通过靶向 FEN1 抑制卵巢癌进展。
J Ovarian Res. 2022 Mar 4;15(1):32. doi: 10.1186/s13048-022-00959-5.
6
The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma.非编码RNA在肝细胞癌索拉非尼耐药中的作用
Front Oncol. 2021 Jul 22;11:696705. doi: 10.3389/fonc.2021.696705. eCollection 2021.
7
FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERα/cyclin D1/Rb axis.FEN1是雌激素受体阳性(ER+)乳腺癌的一种预后生物标志物,并且通过雌激素受体α/细胞周期蛋白D1/视网膜母细胞瘤蛋白(ERα/cyclin D1/Rb)轴与他莫昔芬耐药相关。
Ann Transl Med. 2021 Feb;9(3):258. doi: 10.21037/atm-20-3068.
8
Role and clinical significance of TGF‑β1 and TGF‑βR1 in malignant tumors (Review).转化生长因子-β1(TGF-β1)及其受体 1(TGF-βR1)在恶性肿瘤中的作用及其临床意义(综述)。
Int J Mol Med. 2021 Apr;47(4). doi: 10.3892/ijmm.2021.4888. Epub 2021 Feb 19.
9
Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression.梓醇通过调控 miR-140-5p 的表达抑制 HCC 细胞的增殖、迁移和转移。
Mol Med Rep. 2021 Jan;23(1). doi: 10.3892/mmr.2020.11667. Epub 2020 Nov 12.
10
Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.基于 10 个免疫基因特征的肝细胞癌预后标志物的鉴定。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20200894.
长链非编码 RNA SBF2-AS1 通过调控 miR-140-5p-TGFBR1 通路促进肝癌进展。
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2826-2832. doi: 10.1016/j.bbrc.2018.08.047. Epub 2018 Aug 14.
4
LncRNA SNHG20 promotes cell proliferation and invasion via miR-140-5p-ADAM10 axis in cervical cancer.长链非编码 RNA SNHG20 通过 miR-140-5p-ADAM10 轴促进宫颈癌中的细胞增殖和侵袭。
Biomed Pharmacother. 2018 Jun;102:749-757. doi: 10.1016/j.biopha.2018.03.024. Epub 2018 Apr 5.
5
Curcumin increases breast cancer cell sensitivity to cisplatin by decreasing FEN1 expression.姜黄素通过降低FEN1表达增加乳腺癌细胞对顺铂的敏感性。
Oncotarget. 2018 Jan 10;9(13):11268-11278. doi: 10.18632/oncotarget.24109. eCollection 2018 Feb 16.
6
MicroRNA-140 Inhibits the Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer.微小RNA-140抑制结直肠癌的上皮-间质转化和转移。
Mol Ther Nucleic Acids. 2018 Mar 2;10:426-437. doi: 10.1016/j.omtn.2017.12.022. Epub 2018 Jan 4.
7
miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.miR-140-5p 通过调节 YES1 抑制胃癌的增殖、迁移和侵袭。
Mol Cancer. 2017 Aug 17;16(1):139. doi: 10.1186/s12943-017-0708-6.
8
Targeting TGF-β Signaling in Cancer.靶向癌症中的转化生长因子-β信号通路
Trends Cancer. 2017 Jan;3(1):56-71. doi: 10.1016/j.trecan.2016.11.008. Epub 2017 Jan 3.
9
FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.FEN1促进非小细胞肺癌的肿瘤进展并赋予顺铂耐药性。
Mol Oncol. 2017 Jun;11(6):640-654. doi: 10.1002/1878-0261.12058. Epub 2017 May 12.
10
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.靶向DNA瓣内切核酸酶1以阻碍乳腺癌进展。
EBioMedicine. 2016 Dec;14:32-43. doi: 10.1016/j.ebiom.2016.11.012. Epub 2016 Nov 10.